 DELRAY BEACH, Fla., Feb. 08, 2021 GLOBE NEWSWIRE -- AzurRx BioPharma, Inc. AzurRx or the Company NASDAQ: AZRX, a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal GI diseases, today announced that James Sapirstein, Chief Executive Officer, will present at the BIO CEO Investor Digital Conference taking place February 16-18, 2021. The presentation will be available on demand during the virtual event for all registered attendees. 